Results 21 to 30 of about 83,665 (235)

Leishmaniasis

open access: yesIndian Journal of Critical Care Medicine, 2021
Leishmaniasis is one of the chronic debilitating vector-borne diseases caused by obligate intracellular protozoa. The global burden of disease although not increasing but potential risk of spread is there. At least 20 species of Leishmania are pathogenic to human beings. The transmission is from female sandfly through a blood meal.
Daga, Mradul K   +2 more
openaire   +3 more sources

Exploring Host-Specificity: Untangling the Relationship between Leishmania (Viannia) Species and Its Endosymbiont Leishmania RNA Virus 1

open access: yesMicroorganisms, 2023
A relevant aspect in the epidemiology of Tegumentary Leishmaniasis (TL) are the Leishmania parasites carrying a viral endosymbiont, Leishmania RNA Virus 1 (LRV1), a dsRNA virus.
Mayara Cristhine de Oliveira Santana   +3 more
doaj   +1 more source

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression

open access: yesClinical Case Reports, 2021
Clinicians should always consider rare, atypical, and opportunistic infections in patients undergoing long‐term systemic corticosteroid therapy. Diagnosis needs further evaluations and special consideration.
Maryam Mahdavi   +4 more
doaj   +1 more source

Bayesian geostatistical modeling of leishmaniasis incidence in Brazil [PDF]

open access: yes, 2013
Leishmaniasis is endemic in 98 countries with an estimated 350 million people at risk and approximately 2 million cases annually. Brazil is one of the most severely affected countries.; We applied Bayesian geostatistical negative binomial models to ...
Dimitrios-Alexios Karagiannis-Voules (411801)   +14 more
core   +1 more source

Leishmaniasis: new approaches to disease control. [PDF]

open access: yes, 2003
The leishmaniases afflict the world's poorest populations. Among the two million new cases each year in the 88 countries where the disease is endemic (fig 1), it is estimated that 80% earn less than $2 a day.
Croft, Simon L   +5 more
core   +1 more source

Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent [version 1; peer review: 2 approved]

open access: yesGates Open Research, 2019
Visceral leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania protozoa that are transmitted by female sand flies. On the Indian subcontinent (ISC), VL is targeted by the World Health Organization (WHO) for elimination as a public
NTD Modelling Consortium Visceral Leishmaniasis Group
doaj   +1 more source

Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. [PDF]

open access: yes, 2006
A 20-year (1985-2004) retrospective review of 39 patients with imported visceral leishmaniasis found that tourism to Mediterranean countries and HIV infection were associated with visceral leishmaniasis. Diagnosis was often delayed.
Lawrence John   +7 more
core   +1 more source

Leishmaniasis [PDF]

open access: yeshautnah dermatologie, 2015
ZusammenfassungInfektionen mit Leishmanien gehören zu den Top 3 der häufigsten Reisedermatosen. Je nach Reiseland und Immunstatus des Patienten unterscheiden sich die Krankheitsbilder. Die Infektion bildet sich in 90 % der Fälle als kutane Leishmaniasis aus, kann sich aber auch an den inneren Organen manifestieren (viszerale Leishmaniasis).
openaire   +4 more sources

Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients

open access: yesJournal of Tropical Medicine, 2013
Visceral leishmaniasis (VL) is a parasitic disease characterized by immune suppression. Successful treatment is usually followed by immune reconstitution and a dermatosis called post-Kala-azar dermal leishmaniasis (PKDL).
Eltahir Awad Gasim Khalil   +7 more
doaj   +1 more source

Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice

open access: yesParasites & Vectors, 2020
Background Leishmaniasis is a serious health problem in some parts of the world. In spite of the many known leishmaniasis control measures, the disease has continued to increase in endemic areas, and no effective vaccine has been discovered.
Samira Salari   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy